A Prospective Registry For Patients With Non-Tuberculous Mycobacterial (NTM) Pulmonary Disease in Korea.

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Apr 30, 2019

Keywords

ClinConnect Summary

This clinical trial is focused on understanding and tracking the health of patients with Non-Tuberculous Mycobacterial (NTM) pulmonary disease in Korea. NTM pulmonary disease is a lung infection caused by certain types of bacteria that are not related to tuberculosis. The number of people affected by this disease is growing, and treating it can be very challenging, often requiring long-term use of various antibiotics. By creating a registry, the researchers hope to gather important information about how this disease progresses, the treatments used, and how effective those treatments are.

To be eligible for this study, participants must have a clinical diagnosis of NTM pulmonary disease caused by specific bacteria types, and they should be starting a new treatment regimen. However, individuals who have already been treated for more than four weeks or whose disease is caused by other types of bacteria will not be included. People who join this trial can expect to contribute to a better understanding of NTM pulmonary disease, which may ultimately help improve treatment options in the future. This trial is not yet recruiting participants, so there is still some time before enrollment begins.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Clinical diagnosis of NTM pulmonary disease.
• • 2. The causative agent of NTM pulmonary disease includes: M. avium complex, or M. abscessus subspecies abscessus, or M. abscessus subspecies massiliense, or M. kansasii.
• • 3. Patients who starts new treatment (those who have previous history of treatment are eligible)
• • Exclusion Criteria
• • 1. Patients who have been treated for more than 4 weeks.
• • 2. The causative agent of NTM pulmonary disease is none of M. avium complex, M. abscessus subspecies abscessus, M. abscessus subspecies massiliense, or M. kansasii.